Top

BMC Public Health

Published in:

Open Access 01-12-2014 | Research article

Evidence for low high-density lipoprotein cholesterol levels in Australian indigenous peoples: a systematic review

Authors: Jasmine G Lyons, Kerin O’Dea, Karen Z Walker

Published in: BMC Public Health | Issue 1/2014

Abstract

Background

Low plasma high-density lipoprotein cholesterol (HDL-C) levels are a strong, independent, but poorly understood risk factor for cardiovascular disease (CVD). Although this atherogenic lipid abnormality has been widely reported in Australia’s Indigenous peoples, Aboriginal and Torres Strait Islanders, the evidence has not come under systematic review. This review therefore examines published data for Indigenous Australians reporting 1) mean HDL-C levels for both sexes and 2) factors associated with low HDL-C.

Methods

PubMed, Medline and Informit ATSI Health databases were systematically searched between 1950 and 2012 for studies on Indigenous Australians reporting mean HDL-C levels in both sexes. Retrieved studies were evaluated by standard criteria. Low HDL-C was defined as: <1.0 mmol/L. Analyses of primary data associating measures of HDL-C with other CVD risk factors were also performed.

Results

Fifteen of 93 retrieved studies were identified for inclusion. These provided 58 mean HDL-C levels; 29 for each sex, most obtained in rural/regional (20%) or remote settings (60%) and including 51–1641 participants. For Australian Aborigines, mean HDL-C values ranged between 0.81-1.50 mmol/L in females and 0.76-1.60 mmol/L in males. Two of 15 studies reported HDL-C levels for Torres Strait Islander populations, mean HDL-C: 1.00 or 1.11 mmol/L for females and 1.01 or 1.13 mmol/L for males. Low HDL-C was observed only in rural/regional and remote settings - not in national or urban studies (n = 3) in either gender. Diabetes prevalence, mean/median waist-to-hip ratio and circulating C-reactive protein levels were negatively associated with HDL-C levels (all P < 0.05). Thirty-four per cent of studies reported lower mean HDL-C levels in females than in males.

Conclusions

Very low mean HDL-C levels are common in Australian Indigenous populations living in rural and remote communities. Inverse associations between HDL-C and central obesity, diabetes prevalence and inflammatory markers suggest a particularly adverse CVD risk factor profile. An absence of sex dichotomy in HDL-C levels warrants further investigation.

Available only for authorised users

Vos T, Barker B, Begg S, Stanley L, Lopez AD: Burden of disease and injury in Aboriginal and Torres Strait islander peoples: the indigenous health gap. Int J Epidemiol. 2009, 38: 470-477. 10.1093/ije/dyn240.CrossRefPubMed

Australian Institute of Health and Welfare: The health and welfare of Australia’s Aboriginal and Torres Strait Islander people, an overview 2011. Book The health and welfare of Australia’s Aboriginal and Torres Strait Islander people, an overview 2011. 2011, City: Australian Institute of Health and Welfare

Schutte AE, Shemesh T, Rowley K, Best JD, McDermott R, O’Dea K: The metabolic syndrome and changing relationship between blood pressure and insulin with age, as observed in Aboriginal and Torres Strait islander peoples. Diabet Med. 2005, 22: 1589-1597. 10.1111/j.1464-5491.2005.01747.x.CrossRefPubMed

Luke JN, Brown A, Daniel M, O’Dea K, Best JD, Jenkins AJ, Wang Z, McDermott RA, Wang Z, Rowley KG: The metabolic syndrome and CVD outcomes for a central Australian cohort. Diabetes Res Clin Pract. 2013, 100: e70-e73. 10.1016/j.diabres.2013.03.020.CrossRefPubMed

Einsiedel L, Fernandes L, Joseph S, Brown A, Woodman RJ: Non-communicable diseases, infection and survival in a retrospective cohort of indigenous and non-indigenous adults in central Australia. BMJ Open. 2013, 3 (7): e003070-CrossRefPubMedPubMedCentral

Maguire GP, Nelson C: Acute rheumatic fever and rheumatic heart disease: an insight into Aboriginal health disadvantage and remote Australia. Med J Aust. 2006, 184: 506-PubMed

Maguire GP, Arthur AD, Boustead PJ, Dwyer B, Currie BJ: Clinical experience and outcomes of community-acquired and nosocomial methicillin-resistant Staphylococcus aureus in a northern Australian hospital. J Hosp Infect. 1998, 38: 273-281. 10.1016/S0195-6701(98)90076-7.CrossRefPubMed

McDonald S, Maguire G, Duarte N, Wang XL, Hoy W: C-reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community. Clin Sci (Lond). 2004, 106: 121-128. 10.1042/CS20030186.CrossRef

Gracey M, Spargo RM, Smith P, Smith RM, Burke V, Beilin LJ, Beilby J, Chin C: Risk factors for ill-health in a remote desert-dwelling aboriginal community in Western Australia. Aust NZ J Med. 1996, 26: 171-179. 10.1111/j.1445-5994.1996.tb00881.x.CrossRef

10.

Einsiedel LJ, Woodman RJ: Two nations: racial disparities in bloodstream infections recorded at Alice Springs Hospital, central Australia, 2001–2005. Med J Aust. 2010, 192: 567-571.PubMed

11.

Chirovsky DR, Fedirko V, Cui Y, Sazonov V, Barter P: Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review. Eur J Cardiovasc Prev Rehabil. 2009, 16: 404-423. 10.1097/HJR.0b013e32832c8891.CrossRefPubMed

12.

Barton M: Cholesterol and atherosclerosis: modulation by oestrogen. Curr Opin Lipidol. 2013, 24: 214-220. 10.1097/MOL.0b013e3283613a94.CrossRefPubMed

13.

Kontush A, Chapman MJ: Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev. 2006, 58: 342-374. 10.1124/pr.58.3.1.CrossRefPubMed

14.

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.CrossRef

15.

Alberti KG, Zimmet P, Shaw J: Metabolic syndrome–a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006, 23: 469-480. 10.1111/j.1464-5491.2006.01858.x.CrossRefPubMed

16.

Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Boren J, Catapano AL, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Nordestgaard BG, Ray KK, Reiner Z, Taskinen MR, Tokgozoglu L, Tybjaerg-Hansen A, Watts GF, European Atherosclerosis Society Consensus Panel: Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J. 2011, 32: 1345-1361. 10.1093/eurheartj/ehr112.CrossRefPubMedPubMedCentral

17.

Tonkin A, Barter P, Best J, Boyden A, Furler J, Hossack K, Sullivan D, Thompson P, Vale M, Cooper C, Robinson M, Clune E, National Heart Foundation of Australia, Cardiac Society of Australia and New Zealand: National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005. Heart Lung Circ. 2005, 14: 275-291.CrossRefPubMed

18.

Wyszynski DF, Waterworth DM, Barter PJ, Cohen J, Kesaniemi YA, Mahley RW, McPherson R, Waeber G, Bersot TP, Sharma SS, Nolan V, Middleton LT, Sundseth SS, Farrer LA, Mooser V, Grundy SM: Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). Am J Cardiol. 2005, 95: 194-198. 10.1016/j.amjcard.2004.08.091.CrossRefPubMed

19.

Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, et al: European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2007, 28: 2375-2414.CrossRefPubMed

20.

Shemesh T, Rowley KG, Jenkins A, Brimblecombe J, Best JD, O’Dea K: Differential association of C-reactive protein with adiposity in men and women in an Aboriginal community in northeast Arnhem Land of Australia. Int J Obes (Lond). 2007, 31: 103-108. 10.1038/sj.ijo.0803350.CrossRef

21.

Rowley K, Walker KZ, Cohen J, Jenkins AJ, O’Neal D, Su Q, Best JD, O’Dea K: Inflammation and vascular endothelial activation in an Aboriginal population: relationships to coronary disease risk factors and nutritional markers. Med J Aust. 2003, 178: 495-500.PubMed

22.

McDermott R, Rowley KG, Lee AJ, Knight S, O’Dea K: Increase in prevalence of obesity and diabetes and decrease in plasma cholesterol in a central Australian aboriginal community. Med J Aust. 2000, 172: 480-484.PubMed

23.

Gault A, O’Dea K, Rowley KG, McLeay T, Traianedes K: Abnormal glucose tolerance and other coronary heart disease risk factors in an isolated aboriginal community in central Australia. Diabetes Care. 1996, 19: 1269-1273. 10.2337/diacare.19.11.1269.CrossRefPubMed

24.

Wang Z, Rowley K, Best J, McDermott R, Taylor M, O’Dea K: Hemostatic factors in Australian Aboriginal and Torres Strait islander populations. Metab Clin Exp. 2007, 56: 629-635. 10.1016/j.metabol.2006.12.009.CrossRefPubMed

25.

O’Neal DN, Piers LS, Iser DM, Rowley KG, Jenkins AJ, Best JD, O’Dea K: Australian Aboriginal people and Torres Strait islanders have an atherogenic lipid profile that is characterised by low HDL-cholesterol level and small LDL particles. Atherosclerosis. 2008, 201: 368-377. 10.1016/j.atherosclerosis.2008.03.022.CrossRefPubMed

26.

O’Dea K, Spargo RM, Nestel PJ: Impact of Westernization on carbohydrate and lipid metabolism in Australian Aborigines. Diabetologia. 1982, 22: 148-153.PubMed

27.

Luke JN, Brown AD, Brazionis L, O’Dea K, Best JD, McDermott RA, Wang Z, Wang Z, Rowley KG: Exploring clinical predictors of cardiovascular disease in a central Australian Aboriginal cohort. Eur J Prev Cardiol. 2013, 20: 246-253. 10.1177/2047487312437713.CrossRefPubMed

28.

Sellers EA, Singh GR, Sayers SM: Large waist but low body mass index: the metabolic syndrome in Australian Aboriginal children. J Pediatr. 2008, 153: 222-227. 10.1016/j.jpeds.2008.02.006.CrossRefPubMed

29.

Shemesh T, Rowley KG, Piers LS, Best JD, O’Dea K: Low high-density lipoprotein-cholesterol is the most prevalent metabolic abnormality for Australian Aboriginal men and women even when lean. Eur J Cardiovasc Prev Rehabil. 2008, 15: 49-51. 10.1097/HJR.0b013e3282f0e327.CrossRefPubMed

30.

Sanderson S, Tatt ID, Higgins JP: Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol. 2007, 36: 666-676. 10.1093/ije/dym018.CrossRefPubMed

31.

Snijder MB, Zimmet PZ, Visser M, Dekker JM, Seidell JC, Shaw JE: Independent and opposite associations of waist and hip circumferences with diabetes, hypertension and dyslipidemia: the AusDiab Study. Int J Obes Relat Metab Disord. 2004, 28: 402-409. 10.1038/sj.ijo.0802567.CrossRefPubMed

32.

Li M, McDermott RA: Using anthropometric indices to predict cardio-metabolic risk factors in Australian indigenous populations. Diabetes Res Clin Pract. 2010, 87: 401-406. 10.1016/j.diabres.2009.12.004.CrossRefPubMed

33.

Peiris DP, Patel AA, Cass A, Howard MP, Tchan ML, Brady JP, De Vries J, Rickards BA, Yarnold DJ, Hayman NE, Brown AD: Cardiovascular disease risk management for Aboriginal and Torres Strait Islander peoples in primary health care settings: findings from the Kanyini Audit. Med J Aust. 2009, 191: 304-309.PubMed

34.

Bradshaw PJ, Wilkes ET, Thompson PL: Determinants of carotid intima-medial thickness in an urban Australian Aboriginal population. Atherosclerosis. 2007, 192: 218-223. 10.1016/j.atherosclerosis.2006.05.013.CrossRefPubMed

35.

O’Dea K, Cunningham J, Maple-Brown L, Weeramanthri T, Shaw J, Dunbar T, Zimmet P: Diabetes and cardiovascular risk factors in urban indigenous adults: results from the DRUID study. Diabetes Res Clin Pract. 2008, 80: 483-489. 10.1016/j.diabres.2008.02.008.CrossRefPubMed

36.

Wang Z, Hoy WE: Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people?. Med J Aust. 2005, 182: 66-69.PubMed

37.

O’Dea K, Lion RJ, Lee A, Traianedes K, Hopper JL, Rae C: Diabetes, hyperinsulinemia, and hyperlipidemia in small aboriginal community in northern Australia. Diabetes Care. 1990, 13: 830-835. 10.2337/diacare.13.8.830.CrossRefPubMed

38.

O’Dea K, Patel M, Kubisch D, Hopper J, Traianedes K: Obesity, diabetes, and hyperlipidemia in a central Australian aboriginal community with a long history of acculturation. Diabetes Care. 1993, 16: 1004-1010. 10.2337/diacare.16.7.1004.CrossRefPubMed

39.

Guest CS, O’Dea K, Larkins RG: Blood pressure, lipids and other risk factors for cardiovascular disease in Aborigines and persons of European descent of southeastern Australia. Aust J Public Health. 1994, 18: 79-86.CrossRefPubMed

40.

Minges KE, Zimmet P, Magliano DJ, Dunstan DW, Brown A, Shaw JE: Diabetes prevalence and determinants in Indigenous Australian populations: a systematic review. Diabetes Res Clin Pract. 2011, 93: 139-149. 10.1016/j.diabres.2011.06.012.CrossRefPubMed

41.

Shemesh T, Rowley KG, Jenkins AJ, Best JD, O’Dea K: C-reactive protein concentrations are very high and more stable over time than the traditional vascular risk factors total cholesterol and systolic blood pressure in an Australian aboriginal cohort. Clin Chem. 2009, 55: 336-341.CrossRefPubMed

42.

Maple-Brown LJ, Cunningham J, Nandi N, Hodge A, O’Dea K: Fibrinogen and associated risk factors in a high-risk population: urban indigenous Australians, the DRUID Study. Cardiovasc Diabetol. 2010, 9: 69-10.1186/1475-2840-9-69.CrossRefPubMedPubMedCentral

43.

Maple-Brown LJ, Brimblecombe J, Connelly PW, Harris SB, Mamakeesick M, Zinman B, O’Dea K, Hanley AJ: Similarities and differences in cardiometabolic risk factors among remote Aboriginal Australian and Canadian cohorts. Diabetes Res Clin Pract. 2013, 100: 133-141. 10.1016/j.diabres.2012.12.017.CrossRefPubMed

44.

Hodge AM, Maple-Brown L, Cunningham J, Boyle J, Dunbar T, Weeramanthri T, Shaw J, O’Dea K: Abdominal obesity and other risk factors largely explain the high CRP in indigenous Australians relative to the general population, but not gender differences: a cross-sectional study. BMC Public Health. 2010, 10: 700-10.1186/1471-2458-10-700.CrossRefPubMedPubMedCentral

45.

Kao PC, Shiesh SC, Wu TJ: Serum C-reactive protein as a marker for wellness assessment. Ann Clin Lab Sci. 2006, 36: 163-169.PubMed

46.

Hoy WE, Norman RJ, Hayhurst BG, Pugsley DJ: A health profile of adults in a Northern territory aboriginal community, with an emphasis on preventable morbidities. Aust N Z J Public Health. 1997, 21: 121-126. 10.1111/j.1467-842X.1997.tb01670.x.CrossRefPubMed

47.

Eades SJ, Taylor B, Bailey S, Williamson AB, Craig JC, Redman S, Investigators S: The health of urban Aboriginal people: insufficient data to close the gap. Med J Aust. 2010, 193: 521-524.PubMed

48.

Dunstan DW, Zimmet PZ, Welborn TA, Cameron AJ, Shaw J, de Courten M, Jolley D, McCarty DJ, Australian Diabetes O: The Australian diabetes, obesity and lifestyle study (AusDiab)–methods and response rates. Diabetes Res Clin Pract. 2002, 57: 119-129. 10.1016/S0168-8227(02)00025-6.CrossRefPubMed

49.

Janus ED, Tideman PA, Dunbar JA, Kilkkinen A, Bunker SJ, Philpot B, Tirimacco R, Mc Namara K, Heistaro S, Laatikainen T: Dyslipidaemia in rural Australia: prevalence, awareness, and adherence to treatment guidelines in the greater green triangle risk factor study. Med J Aust. 2010, 192: 127-132.PubMed

50.

Peloso GM, Demissie S, Collins D, Mirel DB, Gabriel SB, Cupples LA, Robins SJ, Schaefer EJ, Brousseau ME: Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease. J Lipid Res. 2010, 51: 3524-3532. 10.1194/jlr.P008268.CrossRefPubMedPubMedCentral

51.

Boes E, Coassin S, Kollerits B, Heid IM, Kronenberg F: Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review. Exp Gerontol. 2009, 44: 136-160. 10.1016/j.exger.2008.11.003.CrossRefPubMed

52.

Mahley RW, Pepin J, Palaoglu KE, Malloy MJ, Kane JP, Bersot TP: Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase. High density lipoprotein characterization and gender-specific effects of apolipoprotein e genotype. J Lipid Res. 2000, 41: 1290-1301.PubMed

53.

Kamboh MI, Harmony JA, Sepehrnia B, Nwankwo M, Ferrell RE: Genetic studies of human apolipoproteins. XX. Genetic polymorphism of apolipoprotein J and its impact on quantitative lipid traits in normolipidemic subjects. Am J Hum Genet. 1991, 49: 1167-1173.PubMedPubMedCentral

54.

Shaw JT, Tate J, Kesting JB, Marczak M, Berkholz JR, Lovelock PK, Purdie D, Hickman P, Cameron DP: Apolipoprotein E polymorphism in indigenous Australians: allelic frequencies and relationship with dyslipidaemia. Med J Aust. 1999, 170: 161-164.PubMed

55.

McNamara BJ, Gubhaju L, Chamberlain C, Stanley F, Eades SJ: Early life influences on cardio-metabolic disease risk in aboriginal populations–what is the evidence? A systematic review of longitudinal and case–control studies. Int J Epidemiol. 2012, 41: 1661-1682. 10.1093/ije/dys190.CrossRefPubMed

56.

Chandalia M, Mohan V, Adams-Huet B, Deepa R, Abate N: Ethnic difference in sex gap in high-density lipoprotein cholesterol between Asian Indians and Whites. J Investig Med. 2008, 56: 574-580.CrossRefPubMed

57.

Chow C, Cardona M, Raju PK, Iyengar S, Sukumar A, Raju R, Colman S, Madhav P, Raju R, Reddy KS, Celermajer D, Neal B: Cardiovascular disease and risk factors among 345 adults in rural India–the Andhra Pradesh rural health initiative. Int J Cardiol. 2007, 116: 180-185. 10.1016/j.ijcard.2006.03.043.CrossRefPubMed

58.

Sarkar S, Das M, Mukhopadhyay B, Chakrabarti C, Majumder PP: High prevalence of metabolic syndrome & its correlates in two tribal populations of India & the impact of urbanization. Indian J Med Res. 2006, 123: 679-686.PubMed

59.

Rode A, Shephard RJ: Modernization of lifestyle, body fat content and body fat distribution: a comparison of Igloolik Inuit and Volochanka nGanasan. Int J Obes Relat Metab Disord. 1995, 19: 709-716.PubMed

60.

Brown A, Carrington MJ, McGrady M, Lee G, Zeitz C, Krum H, Rowley K, Stewart S: Cardiometabolic risk and disease in Indigenous Australians: the heart of the heart study. Int J Cardiol. 2014, 171: 377-383. 10.1016/j.ijcard.2013.12.026.CrossRefPubMed

61.

McDonald E, Bailie R, Brewster D, Morris P: Are hygiene and public health interventions likely to improve outcomes for Australian Aboriginal children living in remote communities? A systematic review of the literature. BMC Public Health. 2008, 8: 153-10.1186/1471-2458-8-153.CrossRefPubMedPubMedCentral

62.

Secombe PJ, Brown A, Kruger PS, Stewart PC: Lipid profiles and persisting inflammation following critical illness in a central Australian population: a prospective longitudinal observational study. Intern Med J. 2013, 43: 445-449. 10.1111/imj.12086.CrossRefPubMed

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/14/545/prepub

Title: Evidence for low high-density lipoprotein cholesterol levels in Australian indigenous peoples: a systematic review
Authors: Jasmine G Lyons
Kerin O’Dea
Karen Z Walker
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: BMC Public Health / Issue 1/2014
Electronic ISSN: 1471-2458
DOI: https://doi.org/10.1186/1471-2458-14-545

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Evidence for low high-density lipoprotein cholesterol levels in Australian indigenous peoples: a systematic review

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2014

WalkMore: a randomized controlled trial of pedometer-based interventions differing on intensity messages

Association of weight misperception with weight loss in a diabetes prevention program

Health effects of single motherhood on children in sub-Saharan Africa: a cross-sectional study

Trend of microbiologically-confirmed tuberculosis in a low-incidence setting with high immigration rates

Protocol for the implementation and evaluation of a community-based intervention seeking to reduce dietary salt intake in Lithgow, Australia

A qualitative study of smoking behavior among the floating population in Shanghai, China